146 related articles for article (PubMed ID: 26239019)
21. Gankyrin promotes epithelial-mesenchymal transition and metastasis in NSCLC through forming a closed circle with IL-6/ STAT3 and TGF-β/SMAD3 signaling pathway.
Wang WP; Sun Y; Lu Q; Zhao JB; Wang XJ; Chen Z; Ni YF; Wang JZ; Han Y; Zhang ZP; Yan XL; Li XF
Oncotarget; 2017 Jan; 8(4):5909-5923. PubMed ID: 27992365
[TBL] [Abstract][Full Text] [Related]
22. FAD104, a regulator of adipogenesis, is a novel suppressor of TGF-β-mediated EMT in cervical cancer cells.
Goto M; Osada S; Imagawa M; Nishizuka M
Sci Rep; 2017 Nov; 7(1):16365. PubMed ID: 29180690
[TBL] [Abstract][Full Text] [Related]
23. LncRNA expression signatures of twist-induced epithelial-to-mesenchymal transition in MCF10A cells.
Hu P; Yang J; Hou Y; Zhang H; Zeng Z; Zhao L; Yu T; Tang X; Tu G; Cui X; Liu M
Cell Signal; 2014 Jan; 26(1):83-93. PubMed ID: 24113349
[TBL] [Abstract][Full Text] [Related]
24. ADAM17 promotes epithelial-mesenchymal transition via TGF-β/Smad pathway in gastric carcinoma cells.
Xu M; Zhou H; Zhang C; He J; Wei H; Zhou M; Lu Y; Sun Y; Ding JW; Zeng J; Peng W; Du F; Gong A
Int J Oncol; 2016 Dec; 49(6):2520-2528. PubMed ID: 27779657
[TBL] [Abstract][Full Text] [Related]
25. Fucoidan induces changes in the epithelial to mesenchymal transition and decreases metastasis by enhancing ubiquitin-dependent TGFβ receptor degradation in breast cancer.
Hsu HY; Lin TY; Hwang PA; Tseng LM; Chen RH; Tsao SM; Hsu J
Carcinogenesis; 2013 Apr; 34(4):874-84. PubMed ID: 23275155
[TBL] [Abstract][Full Text] [Related]
26. Ellagic acid induces cell cycle arrest and apoptosis through TGF-β/Smad3 signaling pathway in human breast cancer MCF-7 cells.
Chen HS; Bai MH; Zhang T; Li GD; Liu M
Int J Oncol; 2015 Apr; 46(4):1730-8. PubMed ID: 25647396
[TBL] [Abstract][Full Text] [Related]
27. DEAR1 is a chromosome 1p35 tumor suppressor and master regulator of TGF-β-driven epithelial-mesenchymal transition.
Chen N; Balasenthil S; Reuther J; Frayna A; Wang Y; Chandler DS; Abruzzo LV; Rashid A; Rodriguez J; Lozano G; Cao Y; Lokken E; Chen J; Frazier ML; Sahin AA; Wistuba II; Sen S; Lott ST; Killary AM
Cancer Discov; 2013 Oct; 3(10):1172-89. PubMed ID: 23838884
[TBL] [Abstract][Full Text] [Related]
28. RNF111/Arkadia is regulated by DNA methylation and affects TGF-β/Smad signaling associated invasion in NSCLC cells.
Chen H; Yang T; Lei Z; Wang L; Yang H; Tong X; Yang WT; Zhao J; Gu Y; Chen Y; Zhang HT
Lung Cancer; 2015 Oct; 90(1):32-40. PubMed ID: 26238425
[TBL] [Abstract][Full Text] [Related]
29. Lipocalin-2 negatively modulates the epithelial-to-mesenchymal transition in hepatocellular carcinoma through the epidermal growth factor (TGF-beta1)/Lcn2/Twist1 pathway.
Wang YP; Yu GR; Lee MJ; Lee SY; Chu IS; Leem SH; Kim DG
Hepatology; 2013 Oct; 58(4):1349-61. PubMed ID: 23696034
[TBL] [Abstract][Full Text] [Related]
30. TGF-β1-induced epithelial-mesenchymal transition and acetylation of Smad2 and Smad3 are negatively regulated by EGCG in human A549 lung cancer cells.
Ko H; So Y; Jeon H; Jeong MH; Choi HK; Ryu SH; Lee SW; Yoon HG; Choi KC
Cancer Lett; 2013 Jul; 335(1):205-13. PubMed ID: 23419524
[TBL] [Abstract][Full Text] [Related]
31. Smad3 linker phosphorylation attenuates Smad3 transcriptional activity and TGF-β1/Smad3-induced epithelial-mesenchymal transition in renal epithelial cells.
Bae E; Kim SJ; Hong S; Liu F; Ooshima A
Biochem Biophys Res Commun; 2012 Oct; 427(3):593-9. PubMed ID: 23022526
[TBL] [Abstract][Full Text] [Related]
32. NamiRNA-enhancer network of miR-492 activates the NR2C1-TGF-β/Smad3 pathway to promote epithelial-mesenchymal transition of pancreatic cancer.
Liu S; He X; Di Y; Li Q; Li F; Ma Y; Chen L; Gao Y; Xu J; Yang S; Xu L; Corpe C; Ling Y; Zhang X; Xu J; Yu W; Wang J
Carcinogenesis; 2023 May; 44(2):153-165. PubMed ID: 36591938
[TBL] [Abstract][Full Text] [Related]
33. VEGF suppresses epithelial-mesenchymal transition by inhibiting the expression of Smad3 and miR‑192, a Smad3-dependent microRNA.
Hong JP; Li XM; Li MX; Zheng FL
Int J Mol Med; 2013 Jun; 31(6):1436-42. PubMed ID: 23588932
[TBL] [Abstract][Full Text] [Related]
34. TWIST expression in hypopharyngeal cancer and the mechanism of TWIST-induced promotion of metastasis.
Yu L; Lu S; Tian J; Ma J; Li J; Wang H; Xu W
Oncol Rep; 2012 Feb; 27(2):416-22. PubMed ID: 21971638
[TBL] [Abstract][Full Text] [Related]
35. Down-regulating ribonuclease inhibitor enhances metastasis of bladder cancer cells through regulating epithelial-mesenchymal transition and ILK signaling pathway.
Xiong D; Liou Y; Shu J; Li D; Zhang L; Chen J
Exp Mol Pathol; 2014 Jun; 96(3):411-21. PubMed ID: 24768914
[TBL] [Abstract][Full Text] [Related]
36. Regulation of complement-dependent cytotoxicity by TGF-β-induced epithelial-mesenchymal transition.
Goswami MT; Reka AK; Kurapati H; Kaza V; Chen J; Standiford TJ; Keshamouni VG
Oncogene; 2016 Apr; 35(15):1888-98. PubMed ID: 26148233
[TBL] [Abstract][Full Text] [Related]
37. NSD2 inhibition suppresses metastasis in cervical cancer by promoting TGF-β/TGF-βRI/SMADs signaling.
Zhu L; Yu CL; Zheng Y
Biochem Biophys Res Commun; 2019 Nov; 519(3):489-496. PubMed ID: 31526565
[TBL] [Abstract][Full Text] [Related]
38. Direct Regulation of Alternative Splicing by SMAD3 through PCBP1 Is Essential to the Tumor-Promoting Role of TGF-β.
Tripathi V; Sixt KM; Gao S; Xu X; Huang J; Weigert R; Zhou M; Zhang YE
Mol Cell; 2016 Nov; 64(3):549-564. PubMed ID: 27746021
[TBL] [Abstract][Full Text] [Related]
39. Upregulation of TrkB promotes epithelial-mesenchymal transition and anoikis resistance in endometrial carcinoma.
Bao W; Qiu H; Yang T; Luo X; Zhang H; Wan X
PLoS One; 2013; 8(7):e70616. PubMed ID: 23936232
[TBL] [Abstract][Full Text] [Related]
40. Jagged1 intracellular domain/SMAD3 complex transcriptionally regulates TWIST1 to drive glioma invasion.
Kim JY; Hong N; Park S; Ham SW; Kim EJ; Kim SO; Jang J; Kim Y; Kim JK; Kim SC; Park JW; Kim H
Cell Death Dis; 2023 Dec; 14(12):822. PubMed ID: 38092725
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]